Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials
Top Cited Papers
- 1 July 2001
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 358 (9275), 9-15
- https://doi.org/10.1016/s0140-6736(00)05249-1
Abstract
No abstract availableThis publication has 31 references indexed in Scilit:
- Predictors of Rehospitalization for Symptomatic Venous Thromboembolism after Total Hip ArthroplastyNew England Journal of Medicine, 2000
- Prolonged Prophylaxis after Joint Replacement: Another Step Sideways?Annals of Internal Medicine, 2000
- Prolonged Prophylaxis with Unfractioned Heparin Is Effective to Reduce Delayed Deep Vein Thrombosis in Total Hip ReplacementRespiration, 1998
- The Incidence of Symptomatic Venous Thromboembolism During and After Prophylaxis With EnoxaparinA Multi-institutional Cohort Study of Patients Who Underwent Hip or Knee ArthroplastyArchives of Internal Medicine, 1998
- Efficacy and Safety of Prolonged Thromboprophylaxis with a Low Molecular Weight Heparin (Dalteparin) after Total Hip Arthroplasty— The Danish Prolonged Prophylaxis (DaPP) StudyThrombosis Research, 1998
- Low-Molecular-Weight Heparin (Enoxaparin) as Prophylaxis against Venous Thromboembolism after Total Hip ReplacementNew England Journal of Medicine, 1996
- Efficacy and Safety of Postdischarge Administration of Enoxaparin in the Prevention of Deep Venous Thrombosis after Total Hip ReplacementDrugs, 1996
- Changes in circulatory indices of thrombosis and fibrinolysis during total knee arthroplasty performed under tourniquetThe Journal of Arthroplasty, 1995
- Systematic Review: Why sources of heterogeneity in meta-analysis should be investigatedBMJ, 1994
- Trends in the Utilization of Primary Total Hip Arthroplasty, 1969 Through 1990: A Population-Based Study in Olmsted County, MinnesotaMayo Clinic Proceedings, 1993